Survey shows tech accelerates cell and gene therapy research
A SelectScience survey exploring the science and tech at the heart of gene therapy
Stay updated with breaking news from Ar T. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A SelectScience survey exploring the science and tech at the heart of gene therapy
Imugene Limited (ASX: IMU), a clinical stage immuno-oncology company, highlighted recent progress across the company's immuno-oncology portfolio....
Gdańsk, Poland – 21 February 2024 – PolTREG S.A. (Warsaw Stock Exchange: PTG), a clinical-stage biotechnology company developing cell...
SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (“Gracell” or the “Company”, NASDAQ:...
Hear about a nascent CRISPR-Cas9 gene editing method used to generate CAR T-cells for next-generation cancer treatment